Immuron (IMRN) EPS (Basic) (2016 - 2024)
Immuron (IMRN) recorded quarterly EPS (Basic) of $28.7 billion in Q4 2024, up 795837401761428.8% quarter-over-quarter from -$0.0 in Q4 2023, and up 795837401761428.8% on a YoY basis from N/an in Q1 2024.
Immuron (IMRN) EPS (Basic) (2016 - 2024) Analysis & Trends
Immuron's EPS (Basic) history runs 9 years deep, the most recent figure standing at $28.7 billion for Q4 2024.
- In Q4 2024, EPS (Basic) rose 795837401761428.8% year-over-year to $28.7 billion; the TTM figure through Sep 2025 stood at $28.7 billion (up 74931970355216.64% YoY), while the FY2025 annual figure was -$1.46, up 26.53% from the prior year.
- EPS (Basic) was $28.7 billion for Q4 2024 at Immuron, up from -$0.0 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $28.7 billion in Q4 2024 to a low of -$0.02 in Q2 2023.
- Historically, EPS (Basic) has averaged $4.1 billion across 5 years, with a median of -$0.0 in 2020.
- The sharpest annual moves came in 2021 and 2024: EPS (Basic) slumped 214.95% in 2021, then jumped 795837401761428.8% in 2024.
- A 5-year view of EPS (Basic) shows it stood at -$0.0 in 2020, then plunged by 214.95% to -$0.0 in 2021, then soared by 10178.56% to $0.02 in 2022, then tumbled by 117.43% to -$0.0 in 2023, then surged by 795837401761428.8% to $28.7 billion in 2024.
- The last three EPS (Basic) figures came in at $28.7 billion (Q4 2024), -$0.0 (Q4 2023), and $0.04 (Q3 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -0.68 |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.06 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.00 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 0.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 4.06 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.06 |
| 10 | Immuron | 921.61 Mn | 921.58 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 28.66 Bn |
| Dec 31, 2023 | 0.00 |
| Sep 28, 2023 | 0.04 |
| Jun 30, 2023 | -0.02 |
| Dec 31, 2022 | 0.02 |
| Dec 31, 2021 | 0.00 |
| Dec 31, 2020 | 0.00 |
| Dec 31, 2019 | 0.00 |
| Dec 31, 2018 | -1,318.25 |
| Dec 31, 2017 | 0.09 |
| Dec 31, 2016 | 0.07 |
| Jun 30, 2016 | -0.06 |